10-K Decoder · All companies

UroGen Pharma Ltd.

URGN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$110M$90.4M+21.4%
Operating income−$125M−$96.8M−29.0%
Net income−$153M−$127M−21.0%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$89.0M$27.5M+224%
Operating income$8.30M−$27.4M
Net income−$1.50M−$33.3M+95.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was UroGen's revenue in FY2025?
$110M in FY2025 (Fiscal year ended Dec 31, 2025), +21.4% vs $90.4M a year earlier, per its 10-K filed Mar 2026.
Was UroGen profitable in FY2025?
No: net income was −$153M and operating income −$125M in FY2025.
What was UroGen's revenue in Q3 2026?
$89.0M (+224% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.